We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$23.2B
AUM Growth
+$1.19B
Cap. Flow
-$399M
Cap. Flow %
-1.72%
Top 10 Hldgs %
11.44%
Holding
1,418
New
187
Increased
581
Reduced
380
Closed
112

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$53.1M
2
EXC icon
Exelon
EXC
+$52.7M
3
ORCL icon
Oracle
ORCL
+$42.5M
4
PH icon
Parker-Hannifin
PH
+$37.9M
5
RYAAY icon
Ryanair
RYAAY
+$37.8M

Top Sells

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$67.8M
2
ECL icon
Ecolab
ECL
+$56.9M
3
FFIV icon
F5
FFIV
+$46.6M
4
RTX icon
RTX Corp
RTX
+$44.1M
5
GIS icon
General Mills
GIS
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 17.9%
2 Healthcare 15.74%
3 Financials 11.81%
4 Industrials 9.62%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CP icon
351
Canadian Pacific Kansas City
CP
$81B
$13.2M 0.06%
392,180
+11,000
+3% +$350K
DE icon
352
Deere & Co
DE
$165B
$13.2M 0.06%
104,830
-24,201
-19% -$2.99M
NWL icon
353
Newell Brands
NWL
$2.21B
$13.1M 0.06%
307,936
+56,694
+23% +$2.77M
PGR icon
354
Progressive
PGR
$128B
$13.1M 0.06%
270,304
-31,872
-11% -$1.49M
YUM icon
355
Yum! Brands
YUM
$41.9B
$13M 0.06%
176,344
+1,559
+0.9% +$117K
EWG icon
356
iShares MSCI Germany ETF
EWG
$1.56B
$12.9M 0.06%
399,153
-69,333
-15% -$2.15M
BIVV
357
DELISTED
Bioverativ Inc. Common Stock
BIVV
$12.8M 0.06%
224,478
+20,191
+10% +$1.18M
UNM icon
358
Unum
UNM
$13.2B
$12.8M 0.06%
+250,300
New +$12.2M
QGEN icon
359
Qiagen
QGEN
$8.62B
$12.8M 0.06%
382,690
+18,171
+5% +$626K
PARA
360
DELISTED
Paramount Global Class B
PARA
$12.7M 0.05%
219,395
+55,500
+34% +$3.51M
NI icon
361
NiSource
NI
$21.5B
$12.7M 0.05%
495,100
+149,300
+43% +$3.93M
IAU icon
362
iShares Gold Trust
IAU
$62.8B
$12.7M 0.05%
514,050
NUAN
363
DELISTED
Nuance Communications, Inc.
NUAN
$12.7M 0.05%
929,751
-12,929
-1% -$185K
DLX icon
364
Deluxe
DLX
$1.25B
$12.6M 0.05%
172,582
-34,035
-16% -$2.37M
DST
365
DELISTED
DST Systems Inc.
DST
$12.6M 0.05%
228,700
+19,900
+10% +$1.09M
GHC icon
366
Graham Holdings Company
GHC
$5.31B
$12.2M 0.05%
20,872
+700
+3% +$409K
ALDR
367
DELISTED
Alder Biopharmaceuticals
ALDR
$12.2M 0.05%
992,083
+661,253
+200% +$6.89M
GPC icon
368
Genuine Parts
GPC
$17.9B
$12.1M 0.05%
126,200
TDC icon
369
Teradata
TDC
$2.88B
$12M 0.05%
353,885
-380,400
-52% -$11.8M
MTG icon
370
MGIC Investment
MTG
$6.47B
$11.9M 0.05%
+951,600
New +$11.1M
CCL icon
371
Carnival Corporation Ltd
CCL
$38.1B
$11.9M 0.05%
183,604
+13,838
+8% +$925K
CBPO
372
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$11.8M 0.05%
128,220
+33,886
+36% +$3.26M
F icon
373
Ford
F
$60.9B
$11.8M 0.05%
981,984
+334,721
+52% +$3.78M
CHD icon
374
Church & Dwight Co
CHD
$23.7B
$11.6M 0.05%
240,300
+6,500
+3% +$330K
AMG icon
375
Affiliated Managers Group
AMG
$9.51B
$11.6M 0.05%
61,100
-10,849
-15% -$1.93M

Similar funds

Axa's Q3 2017 Portfolio in Review

As of Q3 2017, Axa held 1,418 positions worth $23.2B, up 5.4% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Axa's Q3 2017 filing shows 187 new, 581 increased, 380 reduced and 112 closed positions. Its largest new stake was Ryanair: 836,448 shares worth $35.3M. The largest sale was TechnipFMC, an estimated $67.8M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q3 2017 buy was Ryanair: 836,448 shares worth $35.3M.
  • Axa added most to General Motors in Q3 2017, an estimated $53.1M increase.
  • Axa's biggest Q3 2017 reduction was TechnipFMC, cutting an estimated $67.8M.
  • Axa fully exited F5 in Q3 2017, selling an estimated $46.6M.
  • Axa's ten largest holdings make up 11% of its $23.2B portfolio in Q3 2017.
  • Axa opened 187 new positions and closed 112 in Q3 2017.
  • Axa's portfolio value rose 5.4% quarter-over-quarter to $23.2B.

Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.